Karyopharm Therapeutics Inc. (KPTI)
NASDAQ: KPTI · Real-Time Price · USD
0.778
+0.003 (0.34%)
Nov 21, 2024, 4:00 PM EST - Market closed
Karyopharm Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 97 | 99 | 385 | 486 | 1,139 | 1,204 | |
Market Cap Growth | -32.46% | -74.26% | -20.76% | -57.36% | -5.35% | 111.61% | |
Enterprise Value | 231 | 201 | 549 | 595 | 1,079 | 1,133 | |
Last Close Price | 0.78 | 0.86 | 3.40 | 6.43 | 15.48 | 19.17 | |
PS Ratio | 0.62 | 0.68 | 2.45 | 2.32 | 10.54 | 29.43 | |
PB Ratio | -0.65 | -0.73 | -23.11 | -6.10 | 22.54 | 24.18 | |
P/TBV Ratio | - | - | - | - | 22.54 | 24.18 | |
EV/Sales Ratio | 1.56 | 1.38 | 3.50 | 2.84 | 9.99 | 27.70 | |
Debt / Equity Ratio | -1.68 | -2.27 | -18.72 | -3.94 | 4.04 | 3.98 | |
Asset Turnover | 0.65 | 0.49 | 0.47 | 0.68 | 0.36 | 0.13 | |
Inventory Turnover | 4.30 | 1.36 | 1.25 | 1.01 | 1.81 | - | |
Quick Ratio | 2.69 | 3.16 | 5.05 | 3.43 | 4.35 | 5.82 | |
Current Ratio | 3.00 | 3.37 | 5.31 | 3.74 | 4.59 | 6.01 | |
Return on Equity (ROE) | - | - | - | - | -391.29% | -171.36% | |
Return on Assets (ROA) | -34.27% | -27.05% | -26.79% | -19.87% | -35.33% | -37.19% | |
Return on Capital (ROIC) | -49.55% | -34.57% | -33.60% | -25.14% | -42.72% | -44.31% | |
Earnings Yield | -90.64% | -144.44% | -42.94% | -25.54% | -17.23% | -16.58% | |
FCF Yield | -124.80% | -93.59% | -38.88% | -22.09% | -14.08% | -15.87% | |
Buyback Yield / Dilution | -10.23% | -39.51% | -8.84% | -4.41% | -16.28% | -9.11% | |
Total Shareholder Return | -10.23% | -39.51% | -8.84% | -4.41% | -16.28% | -9.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.